くすりのしおり

Self-injection
Published: 7/2018

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Etanerceopt BS 50mg PEN 1.0mL for S.C. Injection MA
 Active ingredient:
(Etanercept (genetical recombination)[Etanercept Biosimilar 1])
 Dosage form:
colorless to yellow injectable preparation in pen
 Print on wrapping:

Effects of this medicine

This medicine suppresses action of TNF, which is considered to be a primary factor of inflammation and pain associated with rheumatoid arthritis, improves the symptoms and prevents the damage of joints and bones.
It is usually used for treatment of rheumatoid arthritis.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
  • If you have infection, tuberculosis, demyelinating disorders such as multiple sclerosis, optic nerve inflammation or its past history, congestive heart failure, blood disorders or its past history, a history of interstitial pneumonia, cancer or its past history.
  • If you have received live vaccines (such as rubella/mumps vaccines) just before use of the medicine.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, for adults, subcutaneously inject 1 kit (50 mg of the active ingredient) at a time once a day, once a week. Strictly follow the instructions.
    The contents of a kit should be used all at once.
  • Avoid injection to the site overlapped to previously injected sites (Inject the medicine at least 3 cm apart from the previous injected site).
    Do not massage the injected site after giving the injection.You (patient) may self-inject this medicine (self injection), only if you want to and the doctor has confirmed that patient meets certain criteria for the self-injection.
  • If you missed a dose, or If you accidentally inject more than your prescribed dose, consult with your doctor or pharmacist.
    Do not stop injecting this medicine on your own judgement without your doctor's instruction.
  • If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
  • Do not stop taking this medicine unless your doctor instructs you to do so.

Precautions while taking this medicine

  • This medicine suppresses your immune response. Take care of yourself to prevent infections: Stay away from a crowd, wash your hands and gargle.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include interstitial lung disease, upper respiratory tract inflammation, oropharyngeal pain, dizziness, anemia, infections (nasopharyngitis, bronchitis, etc.), injection site reactions (erythema, swelling, pain, itching), rash, itching, headache, diarrhea, constipation, abdominal pain and fever.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • Chills, fever, dullness (general) [sepsis, pneumonia (including pneumocystis pneumonia), opportunistic infections such as fungal infection]
  • persistent slight fever, persistent cough (for more than 2 weeks), dullness (general) [tuberculosis]
  • Redness (general), swelling (general), breathlessness [serious allergic reactions]
  • persistent fever, sore throat, paleness of the face [serious blood disorders]
  • decreased vision/diplopia, numbness/pain/motor paralysis [demyelinating disorders]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • Keep out of the reach of children. Store at 2 to 8 degree Celsius and avoid light and freezing.
  • Discard the remainder. Do not store them. If you dispose of unused medicines, seek advice of your pharmacist or medicaol institution about proper disposal of medicines.
  • If you wish to receive vaccination, certainly inform the doctor that you are using this medicine and consult with him or her. DO NOT receive live vaccines (such as rubella/mumps vaccines) while using this medicine because of infection risk of the virus. If you wish to receive vaccination, consult your doctor and receive it before initiation of this medicine.

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z